Does TEDUGLUTIDE Cause Injection site erythema? 105 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Injection site erythema have been filed in association with TEDUGLUTIDE (Gattex). This represents 1.2% of all adverse event reports for TEDUGLUTIDE.
105
Reports of Injection site erythema with TEDUGLUTIDE
1.2%
of all TEDUGLUTIDE reports
2
Deaths
71
Hospitalizations
How Dangerous Is Injection site erythema From TEDUGLUTIDE?
Of the 105 reports, 2 (1.9%) resulted in death, 71 (67.6%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
Yes, Injection site erythema is listed as a known adverse reaction in the official FDA drug label for TEDUGLUTIDE.
What Other Side Effects Does TEDUGLUTIDE Cause?
Vascular device infection (1,009)
Weight decreased (991)
Product dose omission issue (937)
Diarrhoea (779)
Abdominal pain (714)
Nausea (682)
Weight increased (631)
Dehydration (615)
Vomiting (585)
Death (527)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which TEDUGLUTIDE Alternatives Have Lower Injection site erythema Risk?
TEDUGLUTIDE vs TEDUGLUTIDE\WATER
TEDUGLUTIDE vs TEGAFUR
TEDUGLUTIDE vs TEGAFUR\URACIL
TEDUGLUTIDE vs TEGASEROD
TEDUGLUTIDE vs TEGRETOL